{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/KRYS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T09:11:08.984Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8944,"canonical_name":"Krystal Biotech, Inc.","cik":"0001711279","uei":null,"lei":null,"duns":null,"ticker":"KRYS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":31,"clinical":1},"count":32,"timeline":[{"ts":"2026-07-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Krystal Biotech, Inc. — 2026-07-21","url_slug":"/sec/cik-0001711279/8-k/0001711279-26-000050","accession_number":"0001711279-26-000050","importance":35},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Krystal Biotech, Inc. — 2026-06-26","url_slug":"/sec/cik-0001711279/4/0002114900-26-000009","accession_number":"0002114900-26-000009","importance":30},{"ts":"2026-06-25","kind":"sec.form144","reporter":"Thomas John Charles","title":"Officer","shares":1000,"usd_value":347270,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001959173-26-004871","importance":40.069454},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Thomas John Charles","title":"EVP, General Counsel","shares":1000,"price_per_share":347.27,"usd_value":347270,"security_title":"Common Stock","importance":35.34727},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Krystal Biotech, Inc. — 2026-06-25","url_slug":"/sec/cik-0001711279/144/0001959173-26-004871","accession_number":"0001959173-26-004871","importance":30},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Thomas John Charles","title":"EVP, General Counsel","shares":1000,"price_per_share":179.25,"usd_value":179250,"security_title":"Common Stock","importance":15.17925},{"ts":"2026-06-04","kind":"sec.form144","reporter":"KRISH KRISHNAN","title":"Director, Officer, 10% Stockholder","shares":25000,"usd_value":7545500,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001950047-26-005652","importance":41.509100000000004},{"ts":"2026-06-04","kind":"sec.form144","reporter":"SUMA KRISHNAN","title":"Director, Officer, 10% Stockholder","shares":25000,"usd_value":7545500,"security_title":"Common","approx_sale_date":"2026-06-04","accession_number":"0001950047-26-005653","importance":41.509100000000004},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":12729,"price_per_share":307.8066,"usd_value":3918070,"security_title":"Common Stock","importance":38.9180702114},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":11461,"price_per_share":307.6776,"usd_value":3526293,"security_title":"Common Stock","importance":38.5262929736},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":4830,"price_per_share":308.4677,"usd_value":1489899,"security_title":"Common Stock","importance":36.489898991},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":3803,"price_per_share":308.8898,"usd_value":1174708,"security_title":"Common Stock","importance":36.1747079094},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":2801,"price_per_share":309.9451,"usd_value":868156,"security_title":"Common Stock","importance":35.8681562251},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":2784,"price_per_share":309.4901,"usd_value":861620,"security_title":"Common Stock","importance":35.8616204384},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":2652,"price_per_share":310.429,"usd_value":823258,"security_title":"Common Stock","importance":35.823257708},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":2039,"price_per_share":310.937,"usd_value":634001,"security_title":"Common Stock","importance":35.634000543},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":1348,"price_per_share":307.0948,"usd_value":413964,"security_title":"Common Stock","importance":35.4139637904},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":964,"price_per_share":311.358,"usd_value":300149,"security_title":"Common Stock","importance":35.300149112},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":640,"price_per_share":302.2367,"usd_value":193431,"security_title":"Common Stock","importance":35.193431488},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":589,"price_per_share":306.3318,"usd_value":180429,"security_title":"Common Stock","importance":35.1804294302},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":593,"price_per_share":302.2508,"usd_value":179235,"security_title":"Common Stock","importance":35.1792347244},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":544,"price_per_share":304.8102,"usd_value":165817,"security_title":"Common Stock","importance":35.1658167488},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":480,"price_per_share":305.865,"usd_value":146815,"security_title":"Common Stock","importance":35.1468152},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":400,"price_per_share":304.8939,"usd_value":121958,"security_title":"Common Stock","importance":35.12195756},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":320,"price_per_share":300.75,"usd_value":96240,"security_title":"Common Stock","importance":35.09624},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":320,"price_per_share":300.75,"usd_value":96240,"security_title":"Common Stock","importance":35.09624},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":247,"price_per_share":303.1703,"usd_value":74883,"security_title":"Common Stock","importance":35.0748830641},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Suma","title":"President, R&D","shares":240,"price_per_share":311.65,"usd_value":74796,"security_title":"Common Stock","importance":35.074796},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":176,"price_per_share":303.1689,"usd_value":53358,"security_title":"Common Stock","importance":35.0533577264},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Krishnan Krish S","title":"President and CEO","shares":40,"price_per_share":312.23,"usd_value":12489,"security_title":"Common Stock","importance":35.0124892},{"ts":"2026-05-20","kind":"sec.filing","form_type":"8-K","title":"8-K — Krystal Biotech, Inc. — 2026-05-20","url_slug":"/sec/cik-0001711279/8-k/0001711279-26-000047","accession_number":"0001711279-26-000047","importance":35},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Krystal Biotech, Inc.","title":"A Study Assessing KB407 for the Treatment of Cystic Fibrosis","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT05504837","excerpt":"[\"Cystic Fibrosis\"]","importance":30}]}